Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
GLUE
Stock Latest News
Company Announcements
Monte Rosa Therapeutics Earnings Call Highlights Progress and Strategic Shifts
17d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target raised to $17 from $15 at Wedbush
18d ago
GLUE
Premium
Ratings
Promising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics
18d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target lowered to $10 from $11 at Wells Fargo
18d ago
GLUE
Premium
Company Announcements
Monte Rosa Therapeutics Reports Strong Q4 2024 Results
18d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics files $400M mixed securities shelf
18d ago
GLUE
Premium
Company Announcements
Monte Rosa Therapeutics Reports Q4 2024 Financial Results
19d ago
8K
GLUE
Premium
The Fly
Monte Rosa Therapeutics announces anticipated upcoming milestones
19d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics sees cash runway into 2028
19d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
19d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs
19d ago
GLUE
Premium
Pre-Earnings
Monte Rosa Therapeutics, Inc. (GLUE) Q4 Earnings Cheat Sheet
21d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics initiated with an Outperform at LifeSci Capital
27d ago
GLUE
Premium
Company Announcements
Monte Rosa Therapeutics Outlines 2025 Milestones and Financial Strength
3M ago
8K
GLUE
Premium
The Fly
Monte Rosa Therapeutics provide corporate update, key milestones 2025
3M ago
GLUE
Premium
The Fly
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
4M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics appoints Hughes to board of directors
4M ago
GLUE
TEVA
Premium
The Fly
Monte Rosa announces closing of global license agreement with Novartis
4M ago
NVS
GLUE
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
4M ago
GLUE
Premium
Company Announcements
Monte Rosa Highlights Promising Results in Cancer Study
4M ago
8K
GLUE
Premium
The Fly
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
4M ago
GLUE
Premium
Company Announcements
Monte Rosa Therapeutics Expands Pipeline with Novartis Deal
5M ago
GLUE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
